| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Bruce D Given last filed a Form 4 in April 2020, as Chief Operating Officer at ARWR. From March 2015 to April 2020, the filings on record show 0 open-market purchases and 14 sales. Bruce D Given's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 850,730 shares of ARWR. The ARWR filings lean toward selling, a net 784,279 shares.
Shares as reported in the last Form 4 for each company; the most recent is from April 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 42,666 | $14.40 | $614,390.40 | -3.8% | |
| Jan 2, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 20,000 | $11.98 | $239,600.00 | -1.8% | |
| Mar 5, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 20,000 | $6.73 | $134,600.00 | -2.2% | |
| Jan 1, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 20,000 | $3.69 | $73,800.00 | -2.1% |